Congress increases money to beat HIV, but stops short of goal set by advocates by Chris Johnson, Washington Blade | Dec 22, 2020
CMS delays 2 years policy drug makers say undermines copay coupons by John Wilkerson, Inside Health Policy | Dec 22, 2020
CMS approves rule to encourage value-based drug pricing by Michael Brady, Modern Healthcare | Dec 21, 2020
Some QHPs don’t cover PrEP cost-free, advocates seek CMS guidance by Amy Lotven, Inside Health Policy | Dec 18, 2020
New draft of a national HIV strategy doubles down on plan to end the U.S. epidemic by Larry Buhl, The Body: HIV/AIDS Resource | Dec 11, 2020
